Trial site
Tennessee Center for Clinical Trials
- 10running trials
- 5closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Heart failure3 trials
- Obesity3 trials
- Peripheral artery disease3 trials
- Stroke3 trials
- Atrial fibrillation2 trials
- Coronary artery disease2 trials
- Familial hypercholesterolaemia2 trials
- Chronic kidney disease1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- High blood pressure1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Recruiting6 trials
- Completed5 trials
- Active, not recruiting4 trials
- Suspended1 trial
- Lead sponsor
- Amgen3 trials
- Novartis Pharmaceuticals3 trials
- Ionis Pharmaceuticals, Inc.2 trials
- M.A. Med Alliance S.A.2 trials
- Regeneron Pharmaceuticals2 trials
- and 4 more
Running trials
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation2 recruiting
- Heart failure2 recruiting
- Stroke2 recruiting
- Coronary artery disease1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Obesity1 recruiting
- Peripheral artery disease1 recruiting
Closed trials
Completed
Completed
A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026